Ozempic is the only FDA-approved oral peptide GLP-1 medication for adults with type 2 diabetes indicated not only to improve blood sugar, along with diet and exercise, but also to reduce the risk of major cardiovascular events (MACE) such as heart attack, stroke, or death in those who are also at high risk for these events
The sixth is cardiometabolic indication expansion
Importantly, ColonBroom GLP-1 Booster is not a drug, hormone, or prescription medication , and it does not contain liraglutide, semaglutide, or other pharmaceutical GLP-1 agonists
The cost: Youll pay a flat $50 monthly copay
In real-world practice, a SGLT2i and a GLP-1RA are more likely to be initiated sequentially rather than simultaneously, not only for economic reasons but also to improve medication adherence [1]
As a long-acting GLP-1 RA, it is administered once per week